Even if it looks like the pandemic covid-19 started in 2020 has already passed, experts continue to call the caution, encourage the population to continue receiving the booster dose and among other things continuing in the Scientific advances to improve the vaccines and treatments that exist today.
In this research they also opted for New strategies to deal with the virus. One of them is to focus proteins, than the disease use against your own body and which are used by the virus for multiply in the affected person. Being able to avoid this process can be a step forward for research, a step that can be achieved thanks to drugs such as Aplidinus, which is in the process of clinical tests to be used for these purposes.
What is Applidin?
Aplidino and he registered name of the drug created by the Spanish company PharmaMar. It is composed of the plitidepsin, And composed which is extracted from the sea squirt Aplidium albicans, an invertebrate that alone is located in some areas of the Balearic archipelagoin shallow areas.
This drug, if approved for use, could help treat covid in those patients for whom existing treatments and vaccines cannot help. One of the groups that could benefit most from Aplidin are people with the weakened immune systemfor instance.
It’s inside United States of America the place where this treatment has more faith, as reported by Washington Post. As this submission publishes, in a University of California study investigating various drugs that could interrupt the virus’ access to proteins, the Aplidino and its plitidepsin is the most promising for one of its authors, Nevan J. Krogan, since it has been exeffective in mice infected with major covid-19 strains.
Since then he has not been the only one who has shown his confidence in the compound José María Fernández Sousa-Faro, President from PharmaMar, also commented in the II Forum of the Economy of El Español Wake up, Spain! that already they suspected of the antiviral properties from drug and that came to be cured with Aplidin while was admitted from covid-19.
At the end of this year, yes will continue with Phase 3 clinical trials studying the effectiveness from two doses different from plitidepsin in adults allowed from covid. This study is conducted randomly and in various centers.
However, covid isn’t the only disease this drug can help with. Pharmamar’s website highlights uses such as eukaryotic translation inhibitoras well as his effect on him cancer, in power stop the cell cycle of cancer cells, to prevent I am increase and produce your own Death.
